Previous applications of TUS were limited, as they were imprecise and too weak to target areas deeper in the brain. Parkinson ...
A new report examines how Wall Street is turning its attention toward deep tech and bioscience, specifically BCI companies ...
February 2024: Servier announced FDA acceptance and priority review of the NDA for vorasidenib, which could become the first ...
Neuralink has moved to validate its controversial brain-implant technology in the scientific arena by submitting its first ...
Examining a brain at the Neuropathology Brain Bank at Mount Sinai Medical Center in Manhattan. By Jonathan Corum Photographs by Shuran Huang In July, a gunman in Midtown Manhattan left a note that ...